Physicians and researchers say there is no robust clinical evidence that semaglutide or tirzepatide are effective at very small doses, and the drugs arent proven to help patients with many marketed symptoms
We address GLP-1 side effects the same week they come up, with dose adjustments, slower titration, supportive care, and close follow-up
Additional taxes and fees may apply
Newer glucose-lowering drugs and risk of dementia: A meta-analysis of cardiovascular outcome trials
This test, conducted every 3 to 6 months, ensures the medication maintains an active ingredient concentration within 10% of the prescribed level
Encora Health combines in-depth medical expertise , evidence-based GLP-1 therapy , and a deep understanding of Austins unique wellness culture